Caerulein,1-[N2-[N-[4-[[[6-[[5-(hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)-1-oxopentyl]amino]-1-oxohexyl]oxy]methyl]-3-nitrobenzoyl]glycyl]-N5-(1-oxopropyl)-L-ornithine]-2-(6-aminohexanoicacid)-5-L-methionine-, labeled with tritium, [3aS-(3aa,4b,6aa)]- (9CI) (157203-06-0)

Identification
Name:	Caerulein,1-[N2-[N-[4-[[[6-[[5-(hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)-1-oxopentyl]amino]-1-oxohexyl]oxy]methyl]-3-nitrobenzoyl]glycyl]-N5-(1-oxopropyl)-L-ornithine]-2-(6-aminohexanoicacid)-5-L-methionine-, labeled with tritium, [3aS-(3aa,4b,6aa)]- (9CI)
Synonyms:	1H-Thieno[3,4-d]imidazole,caerulein deriv.
CAS:	157203-06-0
Molecular Formula:	C89H120 N18 O27 S4
Molecular Weight:	0
Molecular Structure:
Properties
Safety Data

Other Product

L-Proline,1-[N2-(1-carboxy-3-phenylpropyl)-N6-[N-[N-[6-[[5-(hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)-1-oxopentyl]amino]-1-oxohexyl]-b-alanyl]-b-alanyl]-L-lysyl]-, [3aS-[3aa,4b(R*),6aa]]- (9CI)
L-Proline,1-[N2-(1-carboxy-3-phenylpropyl)-N6-[6-[[5-(hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)-1-oxopentyl]amino]-1-oxohexyl]-L-lysyl]-,[3aS-[3aa,4b(R*),6aa]]- (9CI)
Benzenepropanoic acid,4-[[6-[[5-(hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)-1-oxopentyl]amino]-1-oxohexyl]oxy]-,[3aS-(3aa,4b,6aa)]- (9CI)
Angiotensin II,1-[N-[6-[[5-(hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)-1-oxopentyl]amino]-1-oxohexyl]-L-alanine]-5-L-isoleucine-8-(4-azido-L-phenylalanine)-,[3aS-(3aa,4b,6aa)]- (9CI)
Insulin (cattle),NB-[6-[[5-(hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)-1-oxopentyl]amino]-1-oxohexyl]-,[3aS-(3aa,4b,6aa)]- (9CI)
w-Conotoxin G VIA,2-[N6-[6-[[5-(hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)-1-oxopentyl]amino]-1-oxohexyl]-L-lysine]-,[3aS-(3aa,4b,6aa)]- (9CI)
Hexanoic acid,6-[[5-(hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)-1-oxopentyl]amino]-,4-[3-[(2,5-dioxo-1-pyrrolidinyl)oxy]-3-oxopropyl]phenyl ester, [3aS-(3aa,4b,6aa)]- (9CI)
Vasopressin,1-(3-mercaptopropanoicacid)-8-[N6-[5-(hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)-1-oxopentyl]-L-lysine]-,[3aS-(3aa,4b,6aa)]- (9CI)
Substance P,3-[N6-[5-(hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)-1-oxopentyl]-L-lysine]-,[3aS-(3aa,4b,6aa)]- (9CI)
b-Alanine,N-[N-[N-[5-(hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)-1-oxopentyl]-L-tryptophyl]-L-leucyl]-,[3aS-(3aa,4b,6aa)]- (9CI)
Carbamic acid,[1-[[(2,5-dioxo-1-pyrrolidinyl)oxy]carbonyl]-5-[[6-[[5-(hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)-1-oxopentyl]amino]-1-oxohexyl]amino]pentyl]-,1,1-dimethylethyl ester, [3aS-[3aa,4b(R*),6aa]]- (9CI)
Substance P,1-de-L-arginine-2-de-L-proline-3-[N2-[5-(hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)-1-oxopentyl]-L-lysine]-,[3aS-(3aa,4b,6aa)]- (9CI)
4H-[1,2,4]Triazolo[1,5-a][1,4]benzodiazepine-2-carboxamide,8-chloro-6-(2-chlorophenyl)-N-[2-[[6-[[5-(hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)-1-oxopentyl]amino]-1-oxohexyl]amino]ethyl]-,[3aS-(3aa,4b,6aa)]- (9CI)
Glucagon (swine),N-[5-(hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)-1-oxopentyl]-12-[N6-(1-iminoethyl)-L-lysine]-,monohydrochloride, [3aS-(3aa,4b,6aa)]- (9CI)
Angiotensin II,N-[5-(hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)-1-oxopentyl]-5-L-isoleucine-,[3aS-(3aa,4b,6aa)]- (9CI)
5'-Uridylic acid,2'-deoxy-5-[3-[[5-(hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)-1-oxopentyl]amino]-1-propenyl]-,[3aS-(3aa,4b,6aa)]- (9CI)
Uridine5'-(tetrahydrogen triphosphate),2'-deoxy-5-[3-[[5-(hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)-1-oxopentyl]amino]-1-propenyl]-,[3aS-(3aa,4b,6aa)]- (9CI)
Vasopressin,1-(3-mercaptopropanoicacid)-7-[4-[[5-(hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)-1-oxopentyl]amino]-L-proline]-8-L-arginine-,[3aS-(3aa,4b,6aa)]- (9CI)
Neuropeptide Y (swine),7-[N6-[5-(hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)-1-oxopentyl]-L-lysine]-,[3aS-(3aa,4b,6aa)]- (9CI)
a1-13-Corticotropin,N-[12-[[5-(hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)-1-oxopentyl]amino]-1-oxododecyl]-4-L-norleucine-7-D-phenylalanine-13-L-valinamide-,[3aS-(3aa,4b,6aa)]- (9CI)